NYSE Begins Delisting Accendra Health Stock
Accendra Health Inc., formerly Owens & Minor, now trades on the OTCQB Venture Market after the NYSE cited an abnormally low share price.
Updated on Nov. 20, 2026 in Healthcare

Live Poll
Do you trust large companies to keep their promises to customers as they shrink?
The New York Stock Exchange suspended trading of Accendra Health Inc. shares and began delisting its common stock, citing an abnormally low selling price. The Henrico County, Virginia company, previously known as Owens & Minor, began trading on the OTCQB Venture Market on Tuesday under ticker ACCH.
Why it matters
The delisting follows a steep decline in the company's share price, which traded at less than 3 cents per share on Thursday after nearing $4 earlier this year. The move reflects the financial restructuring the company has undergone since selling its hospital supply business last year.
Accendra's stock fell from almost $4 per share earlier this year to less than 3 cents on Thursday, and the company paid an $80 million cancellation fee after abandoning its $1.36 billion deal to buy Rotech Healthcare Holdings. The source does not indicate whether the company intends to pursue further transactions or how the price decline will be addressed.
The players
Accendra Health Inc.
Accendra Health Inc. is a Henrico County, Virginia-based company that sells home respiratory devices, sleep apnea treatment and breast pumps directly to patients, and was previously known as Owens & Minor.
New York Stock Exchange
The New York Stock Exchange is the largest stock exchange in the United States, operating the market where Accendra's common stock was previously listed.
The details
The NYSE notified Accendra earlier this month that its stock was at risk of delisting because of its low price, and suspended trading this week. The company, which sells home respiratory devices, sleep apnea treatment and breast pumps directly to patients, was formed when Owens & Minor sold its brand name and hospital supply division to a private equity firm.
Timeline
Last year: Owens & Minor sold its hospital supply division, and Accendra pulled out of its Rotech Healthcare deal.
Earlier this month: The NYSE notified Accendra of possible delisting.
This week: The NYSE suspended trading of Accendra shares.
Tuesday: Accendra stock began trading on the OTCQB Venture Market under ticker ACCH.
Market Landscape
The Accendra case applies the NYSE's continued-listing rule on abnormally low share prices to a former Fortune 500 company that had divested its core hospital supply business. It marks a shift for a firm that once ranked No. 407 on the Fortune 500 list and now trades on the OTCQB Venture Market.
Shareholders holding Accendra stock now trade on the over-the-counter market rather than the NYSE, which typically means reduced liquidity and less regulatory oversight. Customers buying respiratory devices, sleep apnea treatment or breast pumps from the company should check how the business change affects their supplier relationship.
The takeaway
A stock's listing status can change quickly when its price falls below exchange thresholds, so investors should watch exchange notices as closely as earnings reports. A company's past restructuring can leave a lasting mark on its valuation, even after it sheds its core business.
Further reading
For more on the sector, explore Healthcare coverage on Wisevoter.
Source note: This article includes information reported by Richmond Times-Dispatch.
Live Poll
Do you trust large companies to keep their promises to customers as they shrink?






